Nabota

HomeNabota

Hello world!

By : Nabota
August 12, 2024
Uncategorized

Discover

How It Works
Why Nabota®
See Results
Journey of Nabota®
FAQ

Privacy Policy

1. Won CH et al. Int J Dermatol. 2015;54(2):227-234. 2. Korean IP Office: Registration No. 10-1339349. 3. United States Patent: US 9,512,418 B2 Dec.6, 2016. 4. Song S, et al. Arch Craniofac Surg. 2018;19(3):168-174. 5. Park KY, et al. Dermatol Surg. 2020;46(12):1657-1660. 6. Beer KR, et al. Dermatol Surg. 2019;45(11):1381-1393. 7. Rzany BJ, et al. Aesthet Surg J. 2020;40(4):413-429. 8. Kaufman-Janette J, et al. Aesthet Surg J. 2021;41(12):1409-1422. 9. Lorenc ZP, et al. Aesthet Surg J. 2021;41(12):1423-1438. 10. PrabotulinumtoxinA : Registered as NABOTATM in Korea and Asia, JEUVEAUTM in the US, and NUCEIVATM in Canada and EU. 11. Evolus Press Release, Feb/01/2019 12. Evolus Press Release, Oct/01/2019. 13. Approved Nabota product information HAS 2023. 14. Botulinum Toxin Injection (Botox) - Treatments. Botulinum Toxin Injection (Botox). (n.d.). https://www.cgh.com.sg/patient-care/conditions-treatments/botulinum-toxin-injection-botox 15. Kumar R, et al. Semin Neurol. 2016;36(1):10-19. 16. Schantz EJ, et al. Microbiol Rev. 1992;56(1):80-99.